Pharmacogenomics is an important and evolving area of medical testing that combines pharmacology and genomics to identify genomic variability that can affect individual drug response. There is a need in the general medical and laboratory communities to understand the fundamentals of pharmacogenomics and the impacts of molecular testing on optimizing drug selection. This certificate program is intended to provide an introduction to pharmacogenomics and to review AMP expert consensus recommendations for standardization of alleles for clinical pharmacogenomic genotyping assays.
This AMP Certificate Program is an update of the very popular NGS101. Whether you’re looking to add Next-Generation Sequencing (NGS) to your lab or need a refresher, this course delivers the most current and useful information to help you in your decision making process. This 7-part course (including 6.50 hrs of CME or CMLE credit) is a comprehensive primer on implementing and running NGS in your laboratory.
While most molecular pathology professionals receive a deep foundation in science and clinical practice, there is still a critical need for training in laboratory management and the soft skills required for operational effectiveness. This certificate program will provide an overview of best practices in many areas of laboratory management and reporting.
This certificate program is designed to give participants a deep dive into the challenges and proposed solutions in bioinformatics for next generation sequencing (NGS) testing. The talks go beyond the typical basics in bioinformatics of detecting simple point mutations and small indels into harder-to-detect genomic anomalies. The talks in this Certificate Program discuss common problems and challenges seen in NGS data. These include strand bias, false positives, homology to interpretation challenges with databases, and HGVS nomenclature and proposed solutions for each of these. Speakers present a closer look at complex bioinformatics pipelines from selected laboratories, as well as an overview of advanced methods and technologies to detect complicated genomic anomalies. These anomalies include structural variants, copy number calling and fusion detection using both short and long read sequencing, as well as DNA and RNA assays.